ENO2/NSE antibody (AA 1-434)
Quick Overview for ENO2/NSE antibody (AA 1-434) (ABIN5541736)
Target
See all ENO2/NSE (ENO2) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 1-434
-
Purification
- Protein-A affinity chromatography
-
Immunogen
- Recombinant human NSE (1-434aa) purified from E. coli
-
Isotype
- IgG2b
-
-
-
-
Application Notes
- The antibody has been tested by ELISA, Western blot analysis to assure specificity and reactivity. Since application varies, however, each investigation should be titrated by the reagent to obtain optimal results.Recommended dilution range for Western blot analysis is 1:500 ~ 1:5000.Recommended starting dilution is 1:1000.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS, pH 7.4 containing 0.02 % Sodium Azide and 10 % Glycerol
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store undiluted at 2-8°C for up to two weeks or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing. Shelf life: one year from despatch.
-
Expiry Date
- 12 months
-
-
- ENO2/NSE (ENO2) (Enolase 2 (Gamma, Neuronal) (ENO2))
-
Alternative Name
- neuron specific enolase
-
Background
- Neuron-specific enolase (NSE) is a glycolytic isoenzyme which is located in central and peripheral neurons and neuroendocrine cells. This enzyme is released into the CSF when neural tissue is injured. Neoplasms derived from neural or neuroendocrine tissue may release NSE into the blood. NSE is a useful substance that has been detected in patients with certain tumors, namely: neuroblastoma, small cell lung cancer, medullary thyroid cancer, carcinoid tumors, pancreatic endocrine tumors, and melanoma.
-
UniProt
- P09104
Target
-